Skip to main content
NCBI home page
The British Journal of Venereal Diseases logoLink to The British Journal of Venereal Diseases
. 1980 Aug;56(4):255–258. doi: 10.1136/sti.56.4.255

HR 756--a new cephalosporin in the treatment of gonorrhoea caused by ordinary and penicillinase-producing strains of Neisseria gonorrhoeae.

V S Rajan, E H Sng, R Pang, N J Tan, T Thirumoorthy, K L Yeo
PMCID: PMC1045791  PMID: 6253023

Abstract

HR 756, a new cephalosporin, was used in single intramuscular doses of 500 mg to treat 108 men and women with gonorrhoea caused by penicillinase-producing Neisseria gonorrhoeae (PPNG) and non-PPNG. Of 102 patients followed up, 99 (97.05%) were cured. Cure rates for PPNG infections and non-PPNG infections were 98.18% and 95.74% respectively. Few adverse side effects were recorded but possible cross-sensitisation with penicillin was observed. Clinical and laboratory antibiotic susceptibility results correlated well. It is concluded that this drug is safe and effective in treating both PPNG and non-PPNG infectons.

Full text

PDF
255

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arya O. P., Rees E., Percival A., Alergant C. D., Annels E. H., Turner G. C. Epidemiology and treatment of gonorrhoea caused by penicillinase-producing strains in Liverpool. Br J Vener Dis. 1978 Feb;54(1):28–35. doi: 10.1136/sti.54.1.28. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brownlow W. J., Watko L. P., Aucoin E. J., Iglecia-Fernandez R. Treatment of gonorrhoea contracted in the Western Pacific Region. Br J Vener Dis. 1974 Apr;50(2):113–116. doi: 10.1136/sti.50.2.113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Catlin B. W. Iodometric detection of Haemophilus influenzae beta-lactamase: rapid presumptive test for ampicillin resistance. Antimicrob Agents Chemother. 1975 Mar;7(3):265–270. doi: 10.1128/aac.7.3.265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Fowler W., Rahim G., Brown J. D. Clinical experience in the use of cefuroxime in gonorrhoea. Br J Vener Dis. 1978 Dec;54(6):400–402. doi: 10.1136/sti.54.6.400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Fu K. P., Neu H. C. beta-lactamase stability of HR 756, a novel cephalosporin, compared to that of cefuroxime and cefoxitin. Antimicrob Agents Chemother. 1978 Sep;14(3):322–326. doi: 10.1128/aac.14.3.322. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Keys T. F., Halverson C. W., Clarke E. J., Jr Single-dose treatment of gonorrhea with selected antibiotic agents. JAMA. 1969 Nov 3;210(5):857–861. [PubMed] [Google Scholar]
  7. Martin J. E., Armstrong J. H., Smith P. B. New system for cultivation of Neisseria gonorrhoeae. Appl Microbiol. 1974 Apr;27(4):802–805. doi: 10.1128/am.27.4.802-805.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Murray P. R., Christman J. L., Medoff G. In vitro activity of HR 756, a new cephalosporin, against Neisseria gonorrhoeae. Antimicrob Agents Chemother. 1979 Mar;15(3):452–454. doi: 10.1128/aac.15.3.452. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Neu H. C., Aswapokee N., Aswapokee P., Fu K. P. HR 756, a new cephalosporin active against gram-positive and gram-negative aerobic and anaerobic bacteria. Antimicrob Agents Chemother. 1979 Feb;15(2):273–281. doi: 10.1128/aac.15.2.273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Price J. D., Fluker J. L. The efficacy of cefuroxime for the treatment of acute gonorrhoea in men. Br J Vener Dis. 1978 Jun;54(3):165–167. doi: 10.1136/sti.54.3.165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Wise R., Rollason T., Logan M., Andrews J. M., Bedford K. A. HR 756, a highly active cephalosporin: comparison with cefazolin and carbenicillin. Antimicrob Agents Chemother. 1978 Dec;14(6):807–811. doi: 10.1128/aac.14.6.807. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Venereal Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES